Guru Ownership Trend
Guru Analysis for Madrigal Pharmaceuticals, Inc. (MDGL)
Madrigal Pharmaceuticals, Inc. (MDGL), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $829.96 M.
Top institutional holders include John Paulson and Steven Cohen.
Notably, John Paulson has expressed high conviction in this stock, allocating 27.94% of their equity portfolio to it.
Institutional sentiment is currently Bearish. This is evidenced by a $91.29 M net outflow during the quarter.
Recent activity highlights John Hussman who opened a new position. Conversely, Jefferies Group reduced exposure by 69.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Madrigal Pharmaceuticals, Inc. (MDGL)
Major holders include John Paulson ($719.52 M), Steven Cohen ($73.58 M), Renaissance Technologies (RenTech) ($24.67 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 1.55 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $91.29 M, with 1 managers increasing positions and 7 managers reducing holdings.
During the most recent reporting period, 6 managers trimmed their positions, while 1 fully exited MDGL. The total reported sell value was $92.42 M.
Yes, 1 managers opened new positions in MDGL, and 0 increased their existing holdings. The total reported buy value was $1.13 M.
